Expression of the immune gene related to energy metabolism (NDRG1) in Wilms' tumor and its correlation with prognosis

  • 0Department of Pediatric Surgery, Qilu Hospital of Shandong University, Jinan, China.

|

|

Summary

This summary is machine-generated.

NDRG1 is downregulated in Wilms tumor (WT), correlating with poor prognosis and inhibiting tumor growth. This suggests NDRG1 is a potential prognostic biomarker linked to immune cell infiltration in WT.

Area Of Science

  • Oncology
  • Molecular Biology
  • Cancer Research

Background

  • Wilms tumor (WT) is a pediatric kidney cancer with varying prognoses.
  • Understanding the molecular mechanisms driving WT progression is crucial for improving patient outcomes.

Purpose Of The Study

  • To investigate the expression of NDRG1 in Wilms tumor.
  • To analyze the correlation between NDRG1 expression and WT prognosis.
  • To elucidate the role and potential mechanisms of NDRG1 in WT development and progression.

Main Methods

  • NDRG1 expression was analyzed in WT cohorts (TARGET, GSE138869).
  • Prognostic value was assessed using Cox regression, decision curve analysis, and nomograms.
  • Immune infiltration was evaluated using ESTIMATE and CIBERSORT.
  • Downregulation factors were identified via cBioPortal and StarBase.
  • In vitro functional assays (CCK8, Transwell) were performed.

Main Results

  • NDRG1 was downregulated in WT, particularly in patients with unfavorable prognosis and advanced stages.
  • Low NDRG1 expression correlated with a poorer immune microenvironment and reduced immune cell infiltration.
  • Functional enrichment analysis linked NDRG1 to DNA binding, tubulin binding, and glycosaminoglycan binding pathways.
  • Gene Set Enrichment Analysis (GSEA) associated NDRG1 with pathways like the Nod-like receptor signaling pathway and DNA replication.
  • Overexpression of NDRG1 inhibited WT cell proliferation and migration in vitro.

Conclusions

  • NDRG1 is downregulated in Wilms tumor and associated with adverse prognostic factors.
  • NDRG1 expression is linked to the tumor immune microenvironment and immune cell infiltration.
  • NDRG1 may serve as a promising prognostic biomarker for Wilms tumor.

Related Concept Videos

mTOR Signaling and Cancer Progression 03:03

3.9K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Tumor Progression 02:07

6.5K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

The Retinoblastoma Gene 01:20

4.2K

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

Tumor Immunotherapy 01:27

675

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Canonical Wnt Signaling Pathway 02:54

9.0K

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...

Abnormal Proliferation 02:23

4.6K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...